Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[3]  M. Seiki,et al.  Integrated functions of membrane‐type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase , 2017, Cancer science.

[4]  J. S. Weng,et al.  Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth , 2017, Oncogenesis.

[5]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[6]  Chien-Feng Li,et al.  Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist , 2017, Oncogene.

[7]  Z. Wang,et al.  Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel , 2017, OncoTargets and therapy.

[8]  Y. Murakami,et al.  Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes , 2017, Proceedings of the National Academy of Sciences.

[9]  Yi Lu,et al.  Skp2 is associated with paclitaxel resistance in prostate cancer cells. , 2016, Oncology reports.

[10]  T. Shimamura,et al.  NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells , 2016, Scientific Reports.

[11]  Jean Paul Thiery,et al.  EMT: 2016 , 2016, Cell.

[12]  G. Semenza,et al.  HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells , 2015, Proceedings of the National Academy of Sciences.

[13]  J. S. Weng,et al.  Hypoxia-Inducible Factor 1 Regulation through Cross Talk between mTOR and MT1-MMP , 2013, Molecular and Cellular Biology.

[14]  M. Hung,et al.  Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression , 2013, Cell.

[15]  P. Tassone,et al.  Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials. , 2013, European journal of cancer.

[16]  J. Hazle,et al.  The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis , 2012, Cell.

[17]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[18]  T. Abe,et al.  Deletion of the Mint3/Apba3 Gene in Mice Abrogates Macrophage Functions and Increases Resistance to Lipopolysaccharide-induced Septic Shock* , 2011, The Journal of Biological Chemistry.

[19]  M. Seiki,et al.  Targeting the Warburg Effect That Arises in Tumor Cells Expressing Membrane Type-1 Matrix Metalloproteinase* , 2011, The Journal of Biological Chemistry.

[20]  M. Seiki,et al.  A Membrane Protease Regulates Energy Production in Macrophages by Activating Hypoxia-inducible Factor-1 via a Non-proteolytic Mechanism* , 2010, The Journal of Biological Chemistry.

[21]  Xinbin Chen,et al.  Examination of the expanding pathways for the regulation of p21 expression and activity. , 2010, Cellular signalling.

[22]  G. Semenza.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics , 2010, Oncogene.

[23]  M. Hidalgo.  Pancreatic cancer. , 2010, The New England journal of medicine.

[24]  M. Seiki,et al.  Mint3 Enhances the Activity of Hypoxia-inducible Factor-1 (HIF-1) in Macrophages by Suppressing the Activity of Factor Inhibiting HIF-1* , 2009, The Journal of Biological Chemistry.

[25]  B. Lüscher,et al.  Post-translational regulation of the tumor suppressor p27KIP1 , 2008, Cellular and Molecular Life Sciences.

[26]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[27]  M. Pagano,et al.  Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer , 2008, Nature Reviews Cancer.

[28]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[29]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[30]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[31]  T. Südhof,et al.  Genetic Analysis of Mint/X11 Proteins: Essential Presynaptic Functions of a Neuronal Adaptor Protein Family , 2006, The Journal of Neuroscience.

[32]  H. Tsuda,et al.  High-level Skp2 Expression in Pancreatic Ductal Adenocarcinoma: Correlation with the Extent of Lymph Node Metastasis, Higher Histological Grade, and Poorer Patient Outcome , 2006, Pancreas.

[33]  E. Stanbridge,et al.  Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. , 2005, Cancer research.

[34]  D. Tindall,et al.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[36]  M. Pagano,et al.  Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase* , 2003, Journal of Biological Chemistry.

[37]  S. Kim,et al.  Skp2 regulates Myc protein stability and activity. , 2003, Molecular cell.

[38]  D. Haines,et al.  SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells , 2003, Oncogene.

[39]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[40]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[41]  A. Gartel,et al.  The Role of the Cyclin-dependent Kinase Inhibitor p 21 in Apoptosis 1 , 2002 .

[42]  J. Mestan,et al.  Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[44]  G. Arteel,et al.  Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. , 1999, Radiation research.

[45]  S. Shankland,et al.  Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). , 1999, The Journal of clinical investigation.

[46]  J. Gervais,et al.  Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.